168 related articles for article (PubMed ID: 2292530)
1. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.
Gehanno P; Andrews JM; Ichou F; Sultan E; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():47-51. PubMed ID: 2292530
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.
Dumont R; Guetat F; Andrews JM; Sultan E; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():41-6. PubMed ID: 2292529
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil.
Couraud L; Andrews JM; Lecoeur H; Sultan E; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():35-40. PubMed ID: 2292528
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children.
Bairamis TN; Nikolopoulos TP; Kafetzis DA; Begue P; Lenfant B; Kandiloros DC; Apostolopoulos NJ
J Antimicrob Chemother; 1996 Apr; 37(4):821-4. PubMed ID: 8722549
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.
Borin MT; Hughes GS; Spillers CR; Patel RK
Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.
Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
Saathoff N; Lode H; Neider K; Depperman KM; Borner K; Koeppe P
Antimicrob Agents Chemother; 1992 Apr; 36(4):796-800. PubMed ID: 1354432
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.
Borin MT; Hughes GS; Patel RK; Royer ME; Cathcart KS
J Clin Pharmacol; 1991 Dec; 31(12):1137-45. PubMed ID: 1761737
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.
Kees F; Wellenhofer M; Bröhl K; Grobecker H
Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095
[TBL] [Abstract][Full Text] [Related]
10. Cefpodoxime proxetil concentrations in head and neck tissues.
Theopold HM; Matthias C; Adam D
Infection; 1991; 19(1):41-3. PubMed ID: 2013507
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
Baldwin DR; Wise R; Andrews JM; Honeybourne D
J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
[TBL] [Abstract][Full Text] [Related]
12. A review of the pharmacokinetics of cefpodoxime proxetil.
Borin MT
Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203
[TBL] [Abstract][Full Text] [Related]
13. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C
Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242
[TBL] [Abstract][Full Text] [Related]
14. Effect of food on absorption of cefpodoxime proxetil oral suspension in adults.
Borin MT; Forbes KK
Antimicrob Agents Chemother; 1995 Jan; 39(1):273-5. PubMed ID: 7695323
[TBL] [Abstract][Full Text] [Related]
15. Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.
Muller-Serieys C; Bancal C; Dombret MC; Soler P; Murciano G; Aubier M; Bergogne-Berezin E
Antimicrob Agents Chemother; 1992 Oct; 36(10):2099-103. PubMed ID: 1444291
[TBL] [Abstract][Full Text] [Related]
16. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
17. Disposition of cefpodoxime proxetil in hemodialysis patients.
Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
J Clin Pharmacol; 1992 Nov; 32(11):1038-44. PubMed ID: 1474165
[TBL] [Abstract][Full Text] [Related]
18. Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function.
St Peter JV; Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
Antimicrob Agents Chemother; 1992 Jan; 36(1):126-31. PubMed ID: 1590677
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefpodoxime proxetil in healthy young and elderly volunteers.
Borin MT; Ferry JJ; Forbes KK; Hughes GS
J Clin Pharmacol; 1994 Jul; 34(7):774-81. PubMed ID: 7929873
[TBL] [Abstract][Full Text] [Related]
20. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Frampton JE; Brogden RN; Langtry HD; Buckley MM
Drugs; 1992 Nov; 44(5):889-917. PubMed ID: 1280571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
